Moderna | MRNA - Loan Capital


Moderna reported $597M in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Alnylam Pharmaceuticals USD 2.47B 6.56M Jun/2026
Amgen USD 51.86B 27M Jun/2026
Arrowhead Research USD 1.23B 687.3M Mar/2026
Biogen USD 7.29B 1B Jun/2026
BioMarin Pharmaceutical USD 3.53B 2.1B Jun/2026
Celltrion KRW 411.27B 998.23M Mar/2026
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 50M 30M Mar/2026
Gilead Sciences USD 20.86B 1.27B Mar/2026
GlaxoSmithKline GBP 13.95B 65M Jun/2026
Incyte USD 28.42M 994K Jun/2026
Ionis Pharmaceuticals USD 1.91B 6.62M Jun/2026
Kangmei Pharma CNY 68.57M 9.87M Mar/2026
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
Malin Corporation EUR 0 0 Dec/2024
Moderna USD 597M 6M Jun/2026
Organigram Holdings CAD 60.76M 1.77M Mar/2026
Ovoca Bio EUR 0 0 Jun/2021
Pharma Mar EUR 32.13M 1.04M Jun/2026
Puma Biotechnology USD 10.87M 222K Jun/2025
Qiagen NV USD 1.65B 7.87M Mar/2026
Regeneron Pharmaceuticals USD 1.99B 400K Jun/2026
Sangamo BioSciences USD 0 0 Jun/2022
Sarepta Therapeutics USD 847.62M 9.46M Jun/2026
Sartorius EUR 3.65B 311.1M Jun/2026
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Tilray USD 268.59M 3.82M Sep/2025
Ultragenyx Pharmaceutical USD 1.13B 19M Mar/2026
United Therapeutics USD 100M 100M Jun/2024
Vertex Pharmaceuticals USD 106.7M 4.7M Dec/2025
Zealand Pharma A/S 307M 76.14M Mar/2026
Zz Pientze Pharmaceu CNY 182.29M 4.27M Mar/2026